Global Aminophylline Market, By Indications Bronchospasm, Asthma, Emphysema, Chronic Bronchitis, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Aminophylline Market Analysis and Size
The aminophylline market is expected to witness significant growth during the forecast period. As respiratory diseases are one of the top causes of death according to WHO, aminophylline drugs help in diagnosing the population with these disorders. Moreover, Rapid innovation in personalized medicines with technological advancements will also propel the aminophylline market.
Data Bridge Market Research analyses a growth rate in the aminophylline market in the forecast period 2022-2029. The expected CAGR of aminophylline market is tend to be around 2.50% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Aminophylline is ethylenediamine salt of theophylline. After intake of aminophylline, theophylline is released. Aminophylline relaxes the smooth muscle of the bronchial airways and pulmonary blood vessels and decreases airway responsiveness to histamine, methacholine, adenosine, and allergen. It acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator.
Aminophylline Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Indications (Bronchospasm, Asthma, Emphysema, Chronic Bronchitis, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Bayer AG (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Sun Pharmaceutical Industries Ltd. (India), Hikma Pharmaceutical PLC (U.K), Amneal Pharmaceuticals LLC. (U.S), Aurobindo Pharma (India), Johnsons & Johnsons Private limited (U.S.), Actiza Pharmaceutical Private Limited (India), TORQUE PHARMACEUTICALS PVT. LTD (India), Octapharma AG (Switzerland)
|
|
Market Opportunities
|
|
Global Aminophylline Market Dynamics
Drivers
- Increase in COPD cases
According to WHO, COPD mainly occurs in the underdeveloped countries. In addition to this, a study conducted in 2016 reported 251 million cases of COPD worldwide. Chronic obstructive pulmonary disease is categorized by the symptoms such as shortness of breath, wheezing, frequent coughing, and tightness in the chest. This boost the market growth.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increasing Drug Development and Research Activities
Technological advancements and rapid drug discovery and development innovation, especially in personalized medicine, create significant opportunities for manufacturers in the global aminophylline market. This is another factor expected to drive growth of the aminophylline market.
- Increasing Demand for Retail Pharmacies
The rise in the number of drugs being delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Side Effects of Aminophylline
There are varied side-effects that are associated with aminophylline. Side-effects such as nausea, increased gastric acid secretion, vomiting, polyuria, insomnia, headaches, palpitations, and tremors may hamper the growth of the market.
- High Cost
The huge expenditure associated with these agents hamper the market growth. Different types of aminophyllines are costing high and are hampering the growth of the market.
This global aminophylline market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global aminophylline market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Aminophylline Market
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period. The transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials.
In the post-pandemic era, the biotechnology and pharmaceutical industries are expected to witness a huge future growth due to the demand for vaccines and treatment drugs for COVID-19. Thus, this will leave a significant impact on the global aminophylline market.
Global Aminophylline Market Scope
The global aminophylline market is segmented on the basis of indications, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indications
- Bronchospasm
- Asthma
- Emphysema
- Chronic Bronchitis
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Aminophylline Market Regional Analysis/Insights
The aminophylline market is analyzed and market size insights and trends are provided by indications, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the aminophylline market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing positive growth for aminophylline market throughout the forecasted period due to the increased presence of generic manufacturers and the increasing geriatric population.
North America dominates the market due to the presence of key manufacturers of the product, high research & development, and healthcare expenditure and skilled professionals.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Aminophylline Market Share Analysis
The global aminophylline market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global aminophylline market
Key players operating in the global aminophylline market include:
- Bayer AG (Germany)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sun Pharmaceutical Industries Ltd. (India)
- Hikma Pharmaceutical PLC (U.K.)
- Amneal Pharmaceuticals LLC. (U.S)
- Aurobindo Pharma (India)
- Johnsons & Johnsons Private limited (U.S.)
- Actiza Pharmaceutical Private Limited (India)
- TORQUE PHARMACEUTICALS PVT. LTD (India)
- Octapharma AG (Switzerland)
SKU-